Kongtim相关文献与解析，生知库 | 链接生命科学的每一步

Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA-VEN) results in higher remission rates over conventional 7 + 3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia

维奈托克联合克拉屈滨、伊达比星、阿糖胞苷（CLIA-VEN）方案，在初诊急性髓系白血病患者中，较传统的7+3化疗方案可获得更高的缓解率，且不增加毒性。

Lee, Benjamin J; Griffin, Shawn P; Doh, Jean; Quach, Anthony; Sun, Yujiao; Chumnumsiriwath, Piyatida; Ciurea, Stefan O; Ramos-Perez, Jorge; Bellman, Polina; Jeyakumar, Deepa; Kongtim, Piyanuch; Naqvi, Kiran

白血病

毒理研究

发表日期：2026

文献求助收藏

Budesonide, Added to PTCy-Based Regimen, for Prevention of Acute GI GVHD After Allogeneic Stem Cell Transplantation

布地奈德加入PTCy方案中，用于预防同种异体干细胞移植后急性胃肠道GVHD

期刊:American Journal of Hematology

影响因子:9.9

doi:10.1002/ajh.27581

Kongtim, Piyanuch; Chumnumsiriwath, Piyatida; Vittayawacharin, Pongthep; Jeyakumar, Deepa; Lee, Benjamin J; Doh, Jean; Griffin, Shawn P; Van Etten, Richard A; Ciurea, Stefan

Narsoplimab for refractory transplantation-associated thrombotic microangiopathy (TA-TMA) in adult patients receiving allogeneic hematopoietic stem cell transplantation (AHSCT)

Narsoplimab 用于治疗接受异基因造血干细胞移植 (AHSCT) 的成年患者的难治性移植相关血栓性微血管病 (TA-TMA)

期刊:Bone Marrow Transplantation

影响因子:5.2

doi:10.1038/s41409-025-02595-1

Chumnumsiriwath, Piyatida; Vittayawacharin, Pongthep; Ramos-Perez, Jorge; Jeyakumar, Deepa; Lee, Benjamin J; Doh, Jean; Griffin, Shawn; Nguyen, Matthew; Hanna, Ramy M; Tran, Minh-Ha; Kongtim, Piyanuch; Ciurea, Stefan O

Clinicopathological Prognostic Model for Survival in Adult Patients With Secondary Hemophagocytic Lymphohistiocytosis

成人继发性噬血细胞性淋巴组织细胞增生症患者生存的临床病理预后模型

期刊:European Journal of Haematology

影响因子:2.3

doi:10.1111/ejh.14412

Vittayawacharin, Pongthep; Lee, Benjamin J; E'leimat, Ghayda'; Cao, Yen; Reid, Jack; Gamayo, Ashley; Rezk, Sherif; Brem, Elizabeth A; Lee, Lisa X; Kongtim, Piyanuch; Ciurea, Stefan O

细胞生物学

发表日期：2025

文献求助收藏

Lite-BEAM expands autologous stem cell transplantation access for older or unfit patients with lymphoma

Lite-BEAM 扩大了淋巴瘤老年或体弱患者的自体干细胞移植机会。

期刊:Leukemia & Lymphoma

影响因子:2.2

doi:10.1080/10428194.2025.2547985

Chumnumsiriwath, Piyatida; Vittayawacharin, Pongthep; Pinter-Brown, Lauren; Brem, Elizabeth A; Griffin, Shawn P; Kongtim, Piyanuch; Ciurea, Stefan O

Adoptive cellular therapy after hematopoietic stem cell transplantation

造血干细胞移植后的过继性细胞疗法

期刊:American Journal of Hematology

影响因子:9.9

doi:10.1002/ajh.27204

Vittayawacharin, Pongthep; Kongtim, Piyanuch; Chu, Yaya; June, Carl H; Bollard, Catherine M; Ciurea, Stefan O

Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML

一项使用单倍体 mbIL-21 体外扩增的 NK 细胞治疗多次复发和难治性 AML 患者的 I 期试验结果

期刊:American Journal of Hematology

影响因子:9.9

doi:10.1002/ajh.27281

Ciurea, Stefan O; Kongtim, Piyanuch; Srour, Samer; Chen, Julianne; Soebbing, Doris; Shpall, Elizabeth; Rezvani, Katayoun; Nakkula, Robin; Thakkar, Aarohi; Troy, Ella C; Cash, Alex A; Behbehani, Gregory; Cao, Kai; Schafer, Jolie; Champlin, Richard E; Lee, Dean A

Extending duration of letermovir prophylaxis in haploidentical stem cell transplantation

延长单倍体相合干细胞移植中来特莫韦预防性用药的持续时间

期刊:Haematologica

影响因子:7.9

doi:10.3324/haematol.2024.285766

Vittayawacharin, Pongthep; Lee, Benjamin J; Griffin, Shawn; Doh, Jean; Smith, Julie; Nam, Hannah; Blodget, Emily; Jeyakumar, Deepa; Kongtim, Piyanuch; Ciurea, Stefan O

Persistent Impairment in Immune Reconstitution and Worse Survival Outcomes in Allogeneic Stem Cell Transplantation Patients with Early Coronavirus Disease 2019 Infection

早期感染新型冠状病毒肺炎（COVID-19）的异基因造血干细胞移植患者免疫重建持续受损，生存预后更差

期刊:Transplantation and Cellular Therapy

影响因子:4.4

doi:10.1016/j.jtct.2024.04.021

Lee, Benjamin J; Vittayawacharin, Pongthep; Griffin, Shawn P; Doh, Jean; Nam, Hannah H; Jeyakumar, Deepa; Blodget, Emily; Kongtim, Piyanuch; Ciurea, Stefan O

When the first graft fails: a strategic approach to donor selection for second transplant

第一次移植失败后：第二次移植供体选择的策略

Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA-VEN) results in higher remission rates over conventional 7 + 3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia

维奈托克联合克拉屈滨、伊达比星、阿糖胞苷（CLIA-VEN）方案，在初诊急性髓系白血病患者中，较传统的7+3化疗方案可获得更高的缓解率，且不增加毒性。

Budesonide, Added to PTCy-Based Regimen, for Prevention of Acute GI GVHD After Allogeneic Stem Cell Transplantation

布地奈德加入PTCy方案中，用于预防同种异体干细胞移植后急性胃肠道GVHD

Narsoplimab for refractory transplantation-associated thrombotic microangiopathy (TA-TMA) in adult patients receiving allogeneic hematopoietic stem cell transplantation (AHSCT)

Narsoplimab 用于治疗接受异基因造血干细胞移植 (AHSCT) 的成年患者的难治性移植相关血栓性微血管病 (TA-TMA)

Clinicopathological Prognostic Model for Survival in Adult Patients With Secondary Hemophagocytic Lymphohistiocytosis

成人继发性噬血细胞性淋巴组织细胞增生症患者生存的临床病理预后模型

Lite-BEAM expands autologous stem cell transplantation access for older or unfit patients with lymphoma

Lite-BEAM 扩大了淋巴瘤老年或体弱患者的自体干细胞移植机会。

Adoptive cellular therapy after hematopoietic stem cell transplantation

造血干细胞移植后的过继性细胞疗法

Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML

一项使用单倍体 mbIL-21 体外扩增的 NK 细胞治疗多次复发和难治性 AML 患者的 I 期试验结果

Extending duration of letermovir prophylaxis in haploidentical stem cell transplantation

延长单倍体相合干细胞移植中来特莫韦预防性用药的持续时间

Persistent Impairment in Immune Reconstitution and Worse Survival Outcomes in Allogeneic Stem Cell Transplantation Patients with Early Coronavirus Disease 2019 Infection

早期感染新型冠状病毒肺炎（COVID-19）的异基因造血干细胞移植患者免疫重建持续受损，生存预后更差